Linlin Liu

Linlin Liu has extensive work experience in the pharmaceutical industry. Linlin started their career at WuXi AppTec in 2007, where they held various positions, including Senior Scientist and Group Leader. In 2012, they progressed to the role of Associate Director of Preclinical Project Management, where they were responsible for preclinical development and integrated IND-enabling project management. Linlin joined Shanghai Mab-venture Biopharmaceutical in 2016 as the Director of Nonclinical Development. Currently, Linlin Liu is working at CStone Pharmaceuticals as the Director of Preclinical Project Management and Project Leader.

Linlin Liu earned a Doctor of Philosophy (Ph.D.) in Pharmacology and Toxicology from the Shanghai Institute of Materia Medica between 2002 and 2007. They also have a PMP certification from the PMI-OC Project Management Institute Orange County Chapter, although the specific date of obtaining the certification is not provided.